Increasingly Targeted ADCs Drive NSCLC Treatment Innovations

1 year ago 38

Shirish M, Gadgeel, MD, highlights key treatment advances achieved with antibody-drug conjugates in non–small cell lung cancer.

1. Homepage
2. Lung Cancer
3. Increasingly Targeted ADCs Drive NSCLC Treatment Innovations